Lisata Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Lisata Therapeutics generated cash of -$20,032,000, which is more than the previous year. Cash used in financing activities reached the amount of $385,000 last year. Net change in cash is therefore -$9,561,000.
Cash Flow
| 2014 | -46.89M | -10.73M | 30.67M |
|---|---|---|---|
| 2015 | -39.25M | 3.79M | 36.60M |
| 2016 | -23.66M | -2.84M | 20.90M |
| 2017 | -20.87M | 41.27M | -931.76K |
| 2018 | -19.98M | -4.70M | 824K |
| 2019 | -18.88M | 21.43M | 1.18M |
| 2020 | -8.82M | -7.27M | 18.58M |
| 2021 | -22.24M | -54.89M | 85.27M |
| 2022 | -21.17M | 28.91M | -224K |
| 2023 | -20.03M | 10.10M | 385K |
LSTA Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 32.15M | 24.64M | 16.51M | 14.03M | 10.29M | 34.16M | 14.70M | 20.31M | 19.17M | 46.13M |
Operating activities | ||||||||||
Net income | -20.84M | -54.22M | -27.46M | -8.14M | -19.35M | -16.16M | -16.17M | -33.30M | -81.01M | -55.46M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 189K | 69K | 55K | 63K | 65K | 225K | 372.00K | 2.74M | 2.68M | 2.18M |
Stock-based compensation expense | 2.03M | 2.63M | 2.00M | 1.26M | 1.29M | 0 | 1.96M | 2.60M | 9.75K | 11.20K |
| Deferred income tax benefit | 2.03M | 2.63M | 2.00M | 1.26M | 1.29M | 0 | 1.96M | 2.60M | 9.75K | 11.20K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | -95.68K | -325.62K | 545.17K | -1.19M |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | -571.61K | 269.07K | 1.15M | -2.15M |
Accounts payable | 88K | -223K | 1.25M | -2.83M | -1.86M | -5.90M | 5.66M | -48.69K | 79.25K | 469.82K |
Cash generated by operating activities | -20.03M | -21.17M | -22.24M | -8.82M | -18.88M | -19.98M | -20.87M | -23.66M | -39.25M | -46.89M |
Investing activities | ||||||||||
Purchases Of Investments | -98.47M | -89.68M | -179.77M | -34.79M | -32.93M | -69.69M | -60.15M | 0 | -6.08M | -8.04M |
Investments In Property Plant And Equipment | 0 | -285K | -60K | -20K | 0 | -134K | -135.28K | -2.84M | -3.18M | -3.65M |
Acquisitions Net | 0 | -3.32M | 54.83K | 7.25K | 0 | 2.55M | 67.87M | 0 | 0 | 50.89K |
Cash generated by investing activities | 10.10M | 28.91M | -54.89M | -7.27M | 21.43M | -4.70M | 41.27M | -2.84M | 3.79M | -10.73M |
Financing activities | ||||||||||
Common Stock Issued | 321K | 43K | 85.5M | 18.72M | 1.31M | 1.03M | 5.70M | 11.56M | 36.47M | 16.71M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | -248 | -148 | 0 | -403 | 0 | -72 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | -159K | -6.21M | -10.96M | 133.03K | -4.33M |
Cash used in financing activities | 385K | -224K | 85.27M | 18.58M | 1.18M | 824K | -931.76K | 20.90M | 36.60M | 30.67M |
Net Change In Cash | -9.56M | 7.50M | 8.13M | 2.48M | 3.73M | -23.86M | 19.46M | -5.61M | 1.14M | -26.95M |
Cash at end of period | 22.59M | 32.15M | 24.64M | 16.51M | 14.03M | 10.29M | 34.16M | 14.70M | 20.31M | 19.17M |
| Data source |